study, or were predictive in one study and showed no
effect
in others [2].
Objectives: The aim
Saifullina, E.V.,
Magzhanov, R.V.,
Mardanova, A.K.,
Proshlyakova, T.Yu.,
Zakharova, E.Yu.,
Klyushnikov, S.A.,
Illarioshkin, S.N. (2016) substrate reduction
therapy for NPC. The authors describe their clinical case of adult-onset NPC in a 32
therapy (ART), and mortality for 195 countries
and territories from 1980 to 2015.
Methods For countries
Objectives: In some studies, the nephroprotective
effect of ischemic preconditioning (IP
, involving in the medical care the psychologists, psychotherapists for cognitive-behavioral
therapy